Neggers, S. J., Pronin, V., Balcere, I., Lee, M., Rozhinskaya, L., Bronstein, M. D., . . . van der Lely, A. J. (2015). Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: The LEAD study. Eur J Endocrinol.
Chicago Stili AlıntıNeggers, Sebastian JCMM, et al. "Lanreotide Autogel 120 mg At Extended Dosing Intervals in Patients With Acromegaly Biochemically Controlled With Octreotide LAR: The LEAD Study." Eur J Endocrinol 2015.
MLA AlıntıNeggers, Sebastian JCMM, et al. "Lanreotide Autogel 120 mg At Extended Dosing Intervals in Patients With Acromegaly Biochemically Controlled With Octreotide LAR: The LEAD Study." Eur J Endocrinol 2015.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..